Special features of chronic placental insufficiency treatment in pregnancy complicated by varicose vein disease
- Authors: Ordzhonikidze N.V.1, Gurtovoi B.L.1
-
Affiliations:
- Research Centre of Obstetrics, Gynecology & Perinatology
- Issue: Vol 48, No 5S (1999)
- Pages: 121-121
- Section: Articles
- URL: https://journals.eco-vector.com/jowd/article/view/101277
- DOI: https://doi.org/10.17816/JOWD101277
- ID: 101277
Cite item
Full Text
Abstract
Objective: To determine the Ginkor Fort efficacy (“Beaufour”, France) in combined treatment of chronic placental insufficiency in pregnant women with varicose vein disease.
Present data analysis shows that chronic placental insuffiency in pregnacy complicated by viral and/or bacterial infection is often accompaned (64,1%) by chronic placental incufficiency (CPI).
Full Text
Objective: To determine the Ginkor Fort efficacy (“Beaufour”, France) in combined treatment of chronic placental insufficiency in pregnant women with varicose vein disease.
Present data analysis shows that chronic placental insuffiency in pregnacy complicated by viral and/or bacterial infection is often accompaned (64,1%) by chronic placental incufficiency (CPI).
Methods: There were 60 pregnant women examined with lower extremity vein disease. Chronic placental insufficiency mostly due to infection has been diagnosed at the end of 2nd and at the beginning of 3rd trimester gestation. Among them the main group included 40 patients with CPI who were treated by combined therapy with Ginkor Fort 2 caps.bid during 15-30 days. The control group consisted of 20 pregnant women who were given spasmolytics, essential phospholipids, antiaggregant and anticoagulant drugs. Besides routine clinical exemination taking complaints into account athors studied the following parameters: blood rheology, acid-base balance, gas blood composition, ultrasonic indices of haemodynamic in vessels of mother-placenta-fetus system and in popliteal veins.
Results and conclusion: It has been estimated that Ginkor Fort is an effective drug in combined therapy of placental insufficiency in women with varicose vein disease. This drug allows to exclude various antiaggregants in therapy and to shorten the term of staying in maternity hospital.
About the authors
N. V. Ordzhonikidze
Research Centre of Obstetrics, Gynecology & Perinatology
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow
B. L. Gurtovoi
Research Centre of Obstetrics, Gynecology & Perinatology
Email: info@eco-vector.com
Russian Federation, Moscow